December 4, 2025DiagnosticsOpen Access

68Ga-NY104 PET/CT in the Differential Diagnosis of FDG-Negative Renal Masses: A Two-Case Illustration of Clear Cell Carcinoma Versus Renal Hemangioma

View Full Paper

Ask AI

Bookmark

Authors

XYXinchun Yan YXYichen Xie GZGuo-Yang Zheng

Discussion

Member takes

Implication

Case examples demonstrate 68Ga-NY104 PET/CT improving differential diagnosis of renal masses, suggesting enhanced imaging of clear cell carcinoma and benign renal hemangioma.

Key Points

Clear cell carcinoma was effectively differentiated from renal hemangioma using 68Ga-NY104 imaging, showing improved diagnostic capabilities.
Histopathology confirmed clear cell carcinoma in a patient with significant 68Ga-NY104 uptake, demonstrating promising contrast against FDG PET/CT results.
Differential diagnosis was bolstered by immunohistochemistry outcomes aligning with imaging findings in both case studies.
Prospective evaluation is recommended following successful differentiation in initial imaging scenarios, highlighting potential clinical applications.

Cite This Study

Yan et al. (2025) studied this question.

synapsesocial.com/papers/6930e8d7ea1aef094cca3bb0 https://doi.org/10.3390/diagnostics15233049

View Full Paper

Ask AI

Bookmark

Implication

Case examples demonstrate 68Ga-NY104 PET/CT improving differential diagnosis of renal masses, suggesting enhanced imaging of clear cell carcinoma and benign renal hemangioma.

68Ga-NY104 PET/CT in the Differential Diagnosis of FDG-Negative Renal Masses: A Two-Case Illustration of Clear Cell Carcinoma Versus Renal Hemangioma

Discussion

Member takes

Implication

Key Points

Cite This Study

68Ga-NY104 PET/CT in the Differential Diagnosis of FDG-Negative Renal Masses: A Two-Case Illustration of Clear Cell Carcinoma Versus Renal Hemangioma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider